ArticleFrontiers in pediatrics2026

Gemcitabine-docetaxel therapy in pediatric patients with relapsed or refractory sarcoma: a single-center experience.

Metin Çil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.